If fewer people in Lesotho die of Tuberculosis, more people Lesotho will be able to shop online, benefiting US companies. This simple idea is why a US billionaire or two should promote a program to erradicate TB, with appropriate branding for later gratitude of loyal customers, if desired.
A Copenhagen Consensus peer-reviewed study shows (.pdf | mirror) that a dramatic reduction in tuberculosis world-wide is possible and is one the most effective priorities for improving human survival. Curing tuberculosis (TB) can prevent an astounding 27 million deaths and generate US$3 trillion due to several reasons:
1. Reduction in mortality: TB is a highly infectious disease caused by bacteria that primarily attacks the lungs. If left untreated, it can be fatal. By successfully treating and curing TB, the number of deaths caused by the disease would significantly decrease. This reduction in mortality would directly contribute to preventing 27 million deaths.
2. Economic productivity: TB predominantly affects individuals in their productive years, leading to long periods of illness and even death. Curing TB allows individuals to return to health and resume their productive activities, thereby contributing to the economy. This increased productivity results in economic growth and generates additional income.
3. Healthcare cost savings: TB treatment is often a long and expensive process, especially if the disease progresses to drug-resistant forms. By curing TB, there would be a significant reduction in healthcare costs associated with diagnosing, treating, and managing the disease. These savings can then be redirected towards other healthcare interventions or used for economic development.
4. Improved public health: TB is a highly contagious disease, and individuals with active TB can transmit the infection to others. Curing TB would not only prevent the death of the affected individual but also halt the spread of the disease within communities. This reduction in transmission would result in improved public health, reduced healthcare burden, and overall societal well-being.
5. Reduced burden on healthcare systems: TB places a substantial burden on healthcare systems, particularly in developing countries with limited resources. The cost of treating TB, along with the infrastructure required for its diagnosis and management, can strain healthcare systems. By successfully curing TB, the burden on healthcare systems would be significantly reduced, allowing resources to be allocated for other critical health issues.
Considering these factors, the prevention of 27 million deaths and the economic benefits estimated at US$3 trillion underscore the immense value of investing in TB control programs, research, and treatments.
